PRAKASH MASAND to Depressive Disorder, Treatment-Resistant
This is a "connection" page, showing publications PRAKASH MASAND has written about Depressive Disorder, Treatment-Resistant.
Connection Strength
0.913
-
Key considerations for the use of ketamine and esketamine for the treatment of depression: focusing on administration, safety, and tolerability. Expert Opin Drug Saf. 2022 Jun; 21(6):725-732.
Score: 0.622
-
Ketamine for treatment of mood disorders and suicidality: A narrative review of recent progress. Ann Clin Psychiatry. 2022 02; 34(1):33-43.
Score: 0.153
-
The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. J Affect Disord. 2020 11 01; 276:576-584.
Score: 0.138